ISALT launches transition fund with first investment in medtech company TISSIUM

Through the FSP fund which is financed by seven large French insurance companies

To access this article please sign-in below or register for a free trial.

To access the premium content on Insurance Asset Risk, you must first sign in to your account

Not a subscriber?

Register for a free trial now.